Eliana B Gómez

Trisomy 21 consistently activates the interferon response

Kelly D. Sullivan, Hannah C Lewis, Amanda A. Hill et al. · eLife · 2016 · 383 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies

Benjamin Solomon, Lavinia Tan, Stephen Q. Wong et al. · Journal of Thoracic Oncology · 2020 · 284 citations · Full text

Medicine, Oncology, Pharmacology +17

Pirtobrutinib preclinical characterization: a highly selective, non-covalent (reversible) BTK inhibitor

Eliana B Gómez, Kevin Ebata, Hetal S Randeria et al. · Blood · 2023 · 88 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Conserved Locus-Specific Silencing Functions of Schizosaccharomyces pombe sir2+

Lisa L. Freeman-Cook, Eliana B Gómez, Erik J. Spedale et al. · Genetics · 2004 · 67 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

LOXO-305, A Next Generation Reversible BTK Inhibitor, for Overcoming Acquired Resistance to Irreversible BTK Inhibitors

Barbara J. Brandhuber, Eliana B Gómez, Steven G. Smith et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 62 citations

Medicine, Medicinal Chemistry, Pharmacology +10